P09945 (HIRV2_HIRME) Hirudo medicinalis (Medicinal leech)
Hirudin variant-2 UniProtKBInterProInteractive Modelling
72 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
115 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| THE STRUCTURE OF A COMPLEX OF RECOMBINANT HIRUDIN AND HUMAN ALPHA-THROMBIN |
Heteromer P00734; | 98.46 | ||||
| THE REFINED STRUCTURE OF THE HIRUDIN-THROMBIN COMPLEX |
Heteromer P00734; | 98.36 | 1×NAG; | |||
| Thrombin in complex with 3-chloro-benzamide |
Heteromer P00734; | 100 | 2×NA; 1×WCE; 2×DMS; 1×PO4; 2×GOL; 1×NAG; | |||
| Thrombin in complex with 5-chlorothiophene-2-carboxamide |
Heteromer P00734; | 100 | 2×NA; 1×PO4; 2×DMS; 3×GOL; 2×EDO; 1×FQI; 1×NAG; | |||
| Thrombin in complex with 1-amidinopiperidine |
Heteromer P00734; | 100 | 1×IOD; 3×GOL; 2×NA; 1×PO4; 3×DMS; 1×EDO; 1×MRZ; 1×NAG; | |||
| Thrombin in complex with (S)-1-((R)-2-amino-3-cyclohexylpropanoyl)-N-(4-carbamimidoylbenzyl)pyrroli… |
Heteromer P00734; | 100 | 1×NAG; 3×DMS; 1×PO4; 2×NA; 1×6OV; | |||
| Thrombin Inhibition by Pyridin Derivatives |
Heteromer P00734; | 100 | 1×NAG; 1×06P; 1×PO4; 1×GOL; 2×NA; | |||
| Thrombin in complex with D-Phe-Pro-2-chlorofuran derivative (13l) |
Heteromer P00734; | 100 | 2×NA; 1×NAG; 3×DMS; 1×QKE; | |||
| Thrombin in complex with 1-(2R)-2-amino-3-phenyl-propanoyl-N-(2, 5dichlorophenyl)methylpyrrolidine-… |
Heteromer P00734; | 100 | 2×NA; 1×N6L; 1×PO4; 1×GOL; 1×NAG; | |||
| Thrombin in complex with 4-Methoxy-N-(2-pyridinyl)benzamide |
Heteromer P00734; | 100 | 1×NAG; 2×NA; 2×DMS; 1×SJR; 1×PO4; 3×GOL; 1×EDO; | |||
| Human Thrombin in complex with MI003 |
Heteromer P00734; | 100 | 1×NAG; 1×S00; 1×PO4; 2×GOL; 2×NA; | |||
| Thrombin in complex with ((4-chlorophenyl)sulfamoyl))diemethylamine |
Heteromer P00734; | 100 | 2×NA; 2×DMS; 1×PO4; 1×GOL; 1×Y4L; 1×NAG; | |||
| Human thrombin complexed with fragment-based small molecules occupying the S1 pocket |
Heteromer P00734; | 90.91 | 1×4CP; | |||
| Human Thrombin In Complex With UBTHR104 |
Heteromer P00734; | 100 | 1×NAG; 1×B04; 1×PO4; 1×GOL; 2×NA; | |||
| Thrombin Mutant A190S in complex with (S)-1-(D-phenylalanyl)-N-(4-carbamimidoylbenzyl)pyrrolidine-2… |
Heteromer P00734; | 100 | 5×GOL; 2×DMS; 1×PO4; 2×NA; 1×32U; | |||
| Human Thrombin In Complex With UBTHR105 |
Heteromer P00734; | 100 | 1×NAG; 1×P05; 1×PO4; 3×GOL; 2×NA; | |||
| Thrombin in complex with D-Phe-Pro-m-methoxybenzylamide derivative (16a) |
Heteromer P00734; | 100 | 1×PO4; 2×NA; 1×NAG; 1×GOL; 1×DPN; 1×PRO; 1×SZ4; | |||
| Thrombin in complex with D-Phe-Pro-3-chloro-1,3-dihydroxybenzylamide derivative (13c) |
Heteromer P00734; | 100 | 2×NA; 2×DMS; 1×NAG; 1×PO4; | |||
| Thrombin in complex with MI2105 |
Heteromer P00734; | 100 | 1×KDQ; 1×NAG; 1×PO4; 3×DMS; 2×NA; | |||
| Human Thrombin in complex with MI354 |
Heteromer P00734; | 100 | 1×NAG; 2×S54; 1×PO4; 1×GOL; 2×NA; | |||
| Thrombin Inhibition by Pyridin Derivatives |
Heteromer P00734; | 100 | 1×NAG; 2×NA; 1×PO4; 1×GOL; 1×02P; | |||
| Thrombin in Complex with a D-Phe-Pro-p-benzylamine derivative |
Heteromer P00734; | 100 | 2×NA; 2×DMS; 1×K73; 6×GOL; 1×PO4; 1×NAG; | |||
| Thrombin in complex with (S)-1-((R)-2-amino-3-cyclohexylpropanoyl)-N-(5-chloro-2-(hydroxymethyl)ben… |
Heteromer P00734; | 100 | 1×6TH; 1×NAG; 1×PO4; 1×DMS; 2×NA; 1×EDO; 3×GOL; | |||
| Thrombin in Complex with Methylbenzylamine |
Heteromer P00734; | 100 | 2×NA; 1×02N; 1×PO4; 1×GOL; 1×NAG; | |||
| Human Thrombin in complex with MI004 |
Heteromer P00734; | 100 | 1×NAG; 1×S04; 2×GOL; 1×PO4; 2×NA; | |||
| Human thrombin complexed with fragment-based small molecules occupying the S1 pocket |
Heteromer P00734; | 100 | 1×2CE; | |||
| Thrombin Mutant A190S in complex with (S) -1 - ((R) -2-amino-3,3-diphenylpropanoyl) -N- (3-chlorobe… |
Heteromer P00734; | 100 | 1×23U; 1×DMS; 1×PO4; 5×GOL; 2×NA; | |||
| Thrombin in complex with fragment J02 |
Heteromer P00734; | 100 | 1×NAG; 2×DMS; 1×PO4; 2×NA; 1×F05; | |||
| Thrombin in complex with 3-((5-(tert-butyl)isoxazol-3-yl)methyl)oxetan-3-amine (j54) |
Heteromer P00734; | 100 | 2×NA; 1×PO4; 1×NAG; 2×DMS; 1×D6Y; | |||
| Thrombin in complex with D-Phe-Pro-2-chlorothiophen derivative (16e) |
Heteromer P00734; | 100 | 1×EDO; 2×NA; 1×PO4; 1×NAG; 2×OQZ; 1×DMS; | |||
| Human Thrombin In Complex With MI340 |
Heteromer P00734; | 100 | 1×NAG; 1×M34; 1×PO4; 3×GOL; 2×NA; | |||
| Thrombin in complex with 5-chlorothiophene-2-sulfonamide (j94) |
Heteromer P00734; | 100 | 2×NA; 3×DMS; 1×PO4; 1×NAG; 1×8K2; 1×GOL; | |||
| Thrombin in complex with MI2100 ((S)-N-(2-(aminomethyl)-5-chlorobenzyl)-1-((benzylsulfonyl)-L-argin… |
Heteromer P00734; | 100 | 1×NAG; 2×NA; 2×DMS; 1×EU5; | |||
| Thrombin in Complex with a D-Phe-Pro-imidazole derivative |
Heteromer P00734; | 100 | 2×NA; 1×PO4; 1×DMS; 1×MJH; 1×NAG; | |||
| Human Thrombin In Complex With MI001 |
Heteromer P00734; | 100 | 1×NAG; 1×BJA; 1×PO4; 2×NA; | |||
| Thrombin in complex with (S)-N-(2-(aminomethyl)-5-chlorobenzyl)-1-((benzylsulfonyl)-D-arginyl)pyrro… |
Heteromer P00734; | 100 | 1×2TS; 1×NAG; 2×NA; 2×GOL; 1×DMS; | |||
| Thrombin in complex with D-Phe-Pro-m-Trifluoromethylbenzylamide derivative (phe2) |
Heteromer P00734; | 100 | 2×NA; 1×DMS; 2×PO4; 1×NAG; | |||
| Thrombin in complex with 13k |
Heteromer P00734; | 100 | 2×NA; 1×PO4; 2×DMS; 2×GOL; 1×O5Z; 1×NAG; | |||
| Thrombin in complex with (S)-1-((R)-2-amino-3-cyclohexylpropanoyl)-N-(2-(aminomethyl)-5-chlorobenzy… |
Heteromer P00734; | 100 | 1×NAG; 2×NA; 1×PO4; 1×GOL; 1×DMS; 1×71U; | |||
| Human Thrombin In Complex With MI353 |
Heteromer P00734; | 100 | 1×NAG; 2×TIF; 1×PO4; 2×NA; | |||
| Human Thrombin in complex with MI329 |
Heteromer P00734; | 100 | 1×NAG; 2×S29; 1×PO4; 1×GOL; 2×NA; | |||
| Thrombin Inhibition by Pyridin Derivatives |
Heteromer P00734; | 100 | 1×NAG; 1×10P; 1×GOL; 1×PO4; 2×NA; | |||
| Human Thrombin In Complex With UBTHR97 |
Heteromer P00734; | 100 | 1×NAG; 1×P97; 1×PO4; 2×GOL; 2×NA; | |||
| Human Thrombin in complex with MI331 |
Heteromer P00734; | 100 | 1×NAG; 1×M31; 2×GOL; 1×PO4; 2×NA; | |||
| Thrombin in Complex with a D-DiPhe-Pro-p-pyridine derivative |
Heteromer P00734; | 100 | 1×PO4; 2×NA; 1×DMS; 1×LXW; 1×NAG; | |||
| Thrombin in complex with (2R)-2-(benzylsulfonylamino)-N-(2-((4- carbamimidoylphenyl)methylamino)-2-… |
Heteromer P00734; | 100 | 2×NA; 1×6V2; 1×PO4; 1×NAG; | |||
| Human Thrombin In Complex With UBTHR103 |
Heteromer P00734; | 100 | 1×NAG; 2×NA; 1×GOL; 1×PO4; 1×B03; | |||
| Thrombin in Complex with a D-Phe-Pro-diaminopyridine derivative |
Heteromer P00734; | 100 | 2×DMS; 2×GOL; 2×NA; 1×NAG; 1×PO4; 1×GOZ; | |||
| Thrombin in Complex with a D-Phe-Pro-N-amidinopiperidine Derivative |
Heteromer P00734; | 100 | 1×DMS; 1×PO4; 2×NA; 1×NAG; 1×J3I; 1×TFA; | |||
| Human Thrombin in complex with MI332 |
Heteromer P00734; | 100 | 1×NAG; 1×M32; 2×GOL; 1×PO4; 2×NA; | |||
| Human Thrombin In Complex With MI330 |
Heteromer P00734; | 100 | 1×NAG; 1×S33; 2×GOL; 1×PO4; 2×NA; | |||
| Thrombin in complex with (2R)-2-(benzylsulfonylamino)-N-(2-((4- carbamimidoylphenyl)methylamino)-2-… |
Heteromer P00734; | 100 | 2×NA; 1×3ZD; 1×PO4; 1×NAG; | |||
| Thrombin Mutant A190S in complex with (S)-1-(D-phenylalanyl)-N-(3-chlorobenzyl)pyrrolidine-2-carbox… |
Heteromer P00734; | 100 | 1×22U; 1×DMS; 1×PO4; 6×GOL; 2×NA; | |||
| Thrombin in complex with diphenyl ((4-carbamimidoylphenyl)((S)-1-((R)-3-cyclohexyl 2-((phenylmethyl… |
Heteromer P00734; | 100 | 1×MUZ; 1×NAG; 2×NA; 1×PO4; 2×DMS; | |||
| Thrombin in complex with (2R)-2-(benzylsulfonylamino)-N-((1S)-2-((4- carbamimidoylphenyl)methylamin… |
Heteromer P00734; | 100 | 2×NA; 1×D6J; 1×PO4; 1×NAG; | |||
| Human Thrombin in complex with MI328 |
Heteromer P00734; | 100 | 1×NAG; 1×S28; 1×PO4; 3×GOL; 2×NA; | |||
| Exploring thrombin S3 pocket |
Heteromer P00734; | 100 | 2×NA; 1×50U; | |||
| Thrombin Inhibition by Pyridin Derivatives |
Heteromer P00734; | 100 | 1×NAG; 2×NA; 1×GOL; 1×98P; | |||
| Human Thrombin in complex with MI341 |
Heteromer P00734; | 100 | 1×NAG; 1×M41; 1×PO4; 2×GOL; 2×NA; | |||
| Design and Discovery of Novel, Potent Thrombin Inhibitors with a Solubilizing Cationic P1-P2-Linker |
Heteromer P00734; | 100 | 1×C2D; | |||
| Human Thrombin In Complex With UBTHR101 |
Heteromer P00734; | 100 | 1×NAG; 2×NA; 1×B01; | |||
| thrombin inhibitors |
Heteromer P00734; | 100 | 1×NA; 1×C7M; | |||
| Thrombin in complex with (S)-N-(tert-butyl)-4-(3-(3-carbamimidoylphenyl)-2-((2',4'-dimethoxy-[1,1'-… |
Heteromer P00734; | 100 | 1×MUQ; 1×NAG; 2×NA; 1×DMS; | |||
| 2-(2-Chloro-6-Fluorophenyl)Acetamides as Potent Thrombin Inhibitors |
Heteromer P00734; | 100 | 1×I50; | |||
| thrombin inhibitors |
Heteromer P00734; | 100 | 1×NA; 1×DMS; 1×C2A; | |||
| thrombin inhibitors |
Heteromer P00734; | 100 | 2×DMS; 1×NA; 1×C5M; | |||
| thrombin inhibitors |
Heteromer P00734; | 100 | 3×DMS; 1×NA; 1×C3M; | |||
| thrombin inhibitors |
Heteromer P00734; | 100 | 2×DMS; 1×NA; 1×C4M; | |||
| Thrombin in complex with 3-amidinophenylalanine inhibitor |
Heteromer P00734; | 100 | 1×NAG; 1×0NW; 2×NA; 1×PO4; 2×GOL; | |||
| thrombin inhibitors |
Heteromer P00734; | 100 | 1×DMS; 1×NA; 1×C1M; | |||
| Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to differe… |
Heteromer P00734; | 100 | 1×0G6; 1×NAG; | |||
| Design and Discovery of Novel, Potent Thrombin Inhibitors with a Solubilizing Cationic P1-P2-Linker |
Heteromer P00734; | 100 | 1×C1D; | |||
| Design and Discovery of Novel, Potent Thrombin Inhibitors with a Solubilizing Cationic P1-P2-Linker |
Heteromer P00734; | 100 | 1×5CB; | |||
| Thrombin in complex with benzamidine |
Heteromer P00734; | 100 | 1×NAG; 2×NA; 1×BEN; 1×PO4; 1×GOL; | |||
| Thrombin in Complex with Benzylamine |
Heteromer P00734; | 100 | 2×NA; 2×ABN; 1×GOL; 1×PO4; 1×NAG; | |||
| Thrombin in Complex with a D-Phe-Pro-p-aminopyridine derivative |
Heteromer P00734; | 100 | 1×NAG; 1×J5K; 1×PO4; 1×GOL; 2×NA; | |||
| Thrombin in Complex with a D-Phe-Pro-2-aminopyridine derivative |
Heteromer P00734; | 100 | 1×NAG; 1×PO4; 1×GOL; 2×NA; 1×M6Q; | |||
| Thrombin in Complex with a D-Phe-Pro-p-phenol derivative |
Heteromer P00734; | 100 | 1×NAG; 2×MD8; 1×PO4; 2×NA; | |||
| Thrombin in complex with D-arginine (j77) |
Heteromer P00734; | 100 | 2×NA; 2×DMS; 1×PO4; 1×DAR; 1×NAG; | |||
| Thrombin Inhibitor |
Heteromer P00734; | 100 | 1×GOL; 2×NA; 1×WX5; 1×NAG; | |||
| Thrombin Inhibition by Pyridin Derivatives |
Heteromer P00734; | 100 | 1×NAG; 1×99P; 1×PO4; 2×NA; | |||
| Thrombin in complex with 2-amino-1-(4-bromophenyl)ethan-1-one (j10) |
Heteromer P00734; | 100 | 2×NA; 2×DMS; 2×47A; 1×NAG; | |||
| Thrombin in complex with 4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide (j80) |
Heteromer P00734; | 100 | 2×NA; 2×DMS; 1×PO4; 1×08D; 1×NAG; | |||
| Thrombin in complex with 4-hydroxybenzamide (j89) |
Heteromer P00734; | 100 | 1×PO4; 2×NA; 1×NAG; 2×DMS; 1×HBD; | |||
| Thrombin in Complex with a D-Phe-Pro-2-bromothiophene Derivative |
Heteromer P00734; | 100 | 2×NA; 2×DMS; 1×GOL; 1×NAG; 1×MJK; | |||
| Alpha-thrombin complex with sulfated hirudin (residues 54-65) and L- Arginine template inhibitor CS… |
Heteromer P00734; | 100.0 | 1×MIU; | |||
| Crystal Structure Analysis of thrombin in complex with compound D57, 5-Chlorothiophene-2-carboxylic… |
Heteromer P00734; | 100 | 1×NAG; 2×NA; 1×6XS; | |||
| Exploring thrombin S3 pocket |
Heteromer P00734; | 100 | 2×NA; 1×45U; 1×BEN; 1×GOL; | |||
| Human thrombin-in complex with UB-THR11 |
Heteromer P00734; | 100 | 1×NAG; 1×11U; | |||
| Exploring thrombin S3 pocket |
Heteromer P00734; | 100 | 2×NA; 1×46U; 1×GOL; | |||
| HUMAN THROMBIN-INHIBITOR COMPLEX |
Heteromer P00734; | 100 | 1×NAG; 2×NA; 1×IGN; | |||
| Thrombin in complex with inhibitor |
Heteromer P00734; | 100 | 1×NAG; 1×MVF; 2×NA; | |||
| HUMAN THROMBIN-INHIBITOR COMPLEX |
Heteromer P00734; | 100 | 1×NAG; 2×NA; 1×MEL; | |||
| Crystal structure of thrombin in complex with a novel glucose-conjugated potent inhibitor |
Heteromer P00734; | 100 | 6×DMS; 1×2FN; | |||
| Exploring thrombin S3 pocket |
Heteromer P00734; | 100 | 2×NA; 1×49U; 1×GOL; | |||
| Exploring thrombin S3 pocket |
Heteromer P00734; | 100 | 2×NA; 1×12U; | |||
| HUMAN THROMBIN COMPLEXED WITH NOVEL SYNTHETIC PEPTIDE MIMETIC INHIBITOR AND HIRUGEN |
Heteromer P00734; | 100 | 2×NA; 1×00L; | |||
| HUMAN THROMBIN COMPLEXED WITH NOVEL SYNTHETIC PEPTIDE MIMETIC INHIBITOR AND HIRUGEN |
Heteromer P00734; | 100 | 1×0ZE; 2×NA; | |||
| Exploring thrombin S3 pocket |
Heteromer P00734; | 100 | 2×NA; 1×13U; | |||
| Structure of thrombin inhibited by AERUGINOSIN298-A from a BLUE-GREEN ALGA |
Heteromer P00734; | 100 | 1×NA; | |||
| THROMBIN COMPLEXED WITH HIRUGEN AND A BETA-STRAND MIMETIC INHIBITOR |
Heteromer P00734; | 100 | 2×NA; 1×00K; | |||
| Active site thrombin inhibitors |
Heteromer P00734; | 100 | 1×L03; 3×DMS; | |||
| THROMBIN COMPLEXED WITH A BETA-MIMETIC THIAZOLE-CONTAINING INHIBITOR |
Heteromer P00734; | 100 | 2×NA; 1×00N; | |||
| Human thrombin-in complex with UB-THR10 |
Heteromer P00734; | 100 | 1×NAG; 2×NA; 1×10U; | |||
| HUMAN THROMBIN WITH ACTIVE SITE N-METHYL-D PHENYLALANYL-N-[5-(AMINOIMINOMETHYL)AMINO]-1-{{BENZOTHIA… |
Heteromer P00734; | 100 | 1×00Q; 2×NA; | |||
| MOLECULAR BASIS FOR THE INHIBITION OF HUMAN ALPHA-THROMBIN BY THE MACROCYCLIC PEPTIDE CYCLOTHEONAMI… |
Heteromer P00734; | 100 | ||||
| ACTIVE SITE MIMETIC INHIBITION OF THROMBIN |
Heteromer P00734; | 100 | ||||
| Thrombin in complex with (2R)-2-(benzylsulfonylamino)-N-(2-((4- carbamimidoylphenyl)methylamino)-2-… |
Heteromer P00734; | 100 | 2×NA; 1×UET; 1×PO4; 1×NAG; | |||
| Thrombin Inhibition |
Heteromer P00734; | 100 | 1×91U; 2×NA; | |||
| CRYSTAL STRUCTURES OF THROMBIN WITH THIAZOLE-CONTAINING INHIBITORS: PROBES OF THE S1' BINDING SITE |
Heteromer P00734; | 100 | 2×NA; 1×QWE; | |||
| CRYSTALLOGRAPHIC STRUCTURES OF THROMBIN COMPLEXED WITH THROMBIN RECEPTOR PEPTIDES: EXISTENCE OF EXP… |
Heteromer P00734; | 100 | ||||
| Crystal structure of thrombin in complex with a novel glucose-conjugated potent inhibitor |
Heteromer P00734; | 100 | 6×DMS; 1×2OJ; | |||
| Complex of Recombinant Human Thrombin with a Designed Inhibitor |
Heteromer P00734; | 100 | 1×F25; 1×NA; 1×CA; | |||
| Thrombin in complex with 4-(((1-((2S)-1-((2R)-2-(benzylsulfonylamino)- 3-phenyl-propanoyl)pyrrolidi… |
Heteromer P00734; | 100 | 1×NAG; 2×NA; 2×GOL; 1×S49; 1×PO4; | |||
| Solution structural bundle of bivalirudin - a bivalent hirudin based thrombin inhibitor | monomer | 73.68 | ||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7a0e.1.B | monomer | 0.73 | 83.08 | |||